Karachi, Citi Pharma Ltd. (CITI) today shared its fiscal updates, including a 25% bonus issue, despite not distributing dividends for the year ending June 2023. The share price recorded was 26.01 PKR. The company achieved an EPS of 2.88 PKR for the January to April 2024 period and saw a significant turnover of 95,846,126 shares. Citi Pharma has been a public entity since 2021.